AR and breast carcinoma: There are few reports on ANK3 in cancer, and one showed that ANK3 can be used as a prognostic factor for two primary histologic subtypes of cutaneous melanoma [39] and may be associated with breast cancer prognosis by regulating the androgen receptor signaling pathway [40].